Phase II Selection Design Trial of Concurrent Chemotherapy and Cetuximab Versus Chemotherapy Followed by Cetuximab in Advanced-Stage Non–Small-Cell Lung Cancer: Southwest Oncology Group Study S0342

PURPOSE: Randomized clinical trials failed to show a survival benefit for epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors plus concurrent chemotherapy in patients with metastatic non–small-cell lung cancer (NSCLC), with preclinical data suggesting potential negative interactions....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Herbst, Roy S., Kelly, Karen, Chansky, Kari, Mack, Philip C., Franklin, Wilbur A., Hirsch, Fred R., Atkins, James N., Dakhil, Shaker R., Albain, Kathy S., Kim, Edward S., Redman, Mary, Crowley, John J., Gandara, David R.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2010
Aiheet:
Original Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3020704/
https://ncbi.nlm.nih.gov/pubmed/20921467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.27.9356
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia